HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.

AbstractOBJECTIVE:
To determine the efficacy of systemic acyclovir in decreasing complications and improving the outcome of penetrating keratoplasty for herpes simplex virus (HSV) keratitis.
METHODS:
Retrospective study of 53 primary penetrating keratoplasties for HSV keratitis at an eye hospital from January 1, 1989, through December 31, 1996. Medical records were analyzed for history of HSV keratitis, preoperative neovascularization, and disease activity. Postoperative use of acyclovir, recurrence of HSV keratitis, rejection, uveitis or edema, and graft failure were evaluated.
RESULTS:
Twenty-four patients (mean +/- SD follow-up, 44.7 +/- 32.6 months) received no acyclovir and were compared with 20 patients, (mean +/- SD follow-up, 28.8 +/- 16.7 months), who received 400 mg acyclovir twice a day for at least 1 year. No patient in the acyclovir group had a recurrence of dendritic keratitis in the first year compared with 5 (21%) of the patients who did not receive acyclovir (P = .03). No patient had graft failure in the acyclovir group compared with 4 (17%) in the group without acyclovir after 1 year of follow-up (P = .06).
CONCLUSION:
Postoperative systemic acyclovir therapy after penetrating keratoplasty for HSV keratitis is associated with a reduced rate of recurrent HSV dendritic keratitis and possible graft failure at 1 year of follow-up.
AuthorsF P Tambasco, E J Cohen, L H Nguyen, C J Rapuano, P R Laibson
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 117 Issue 4 Pg. 445-9 (Apr 1999) ISSN: 0003-9950 [Print] United States
PMID10206570 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antiviral Agents
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Administration, Oral
  • Antiviral Agents (therapeutic use)
  • Corneal Edema (prevention & control)
  • Drug Evaluation
  • Female
  • Follow-Up Studies
  • Graft Rejection (prevention & control)
  • Herpesvirus 1, Human
  • Humans
  • Keratitis, Dendritic (drug therapy, surgery)
  • Keratoplasty, Penetrating
  • Male
  • Middle Aged
  • Postoperative Complications (prevention & control)
  • Recurrence
  • Retrospective Studies
  • Uveitis, Anterior (prevention & control)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: